In a development that has brought renewed attention to the darker side of assisted reproductive technologies, the Supreme Court has sought the response of the Union Government after concerns were raised regarding the possibility of child trafficking networks operating through IVF clinics, Assisted Reproductive Technology (ART) centres, and surrogacy facilities. The issue surfaced during the Court’s continuing monitoring of a large child trafficking case, where the amicus curiae highlighted serious regulatory gaps that could potentially be exploited for illegal procurement, transfer, and sale of children under the guise of fertility treatment and surrogacy arrangements.
The matter came before a Bench of Justice J.B. Pardiwala and Justice K. Viswanathan while hearing proceedings arising out of the landmark Pinki v. State of Uttar Pradesh child trafficking case. That litigation has evolved into one of the most significant judicial exercises aimed at addressing organized child trafficking networks operating across different states. Over the past year, the Court has repeatedly expressed concern over the increasing sophistication of trafficking syndicates and has sought systemic reforms to prevent children from being trafficked under various disguises and arrangements.
The latest concern emerged from submissions made by Senior Advocate Aparna Bhat, who is assisting the Court as amicus curiae. She informed the Bench that despite the enactment of the Assisted Reproductive Technology (Regulation) Act, 2021 and the Surrogacy (Regulation) Act, 2021, there is presently no dedicated Standard Operating Procedure specifically designed to identify, prevent, and investigate child trafficking through ART and surrogacy establishments. According to the amicus, the absence of such safeguards creates a potential regulatory blind spot that may be exploited by criminal networks.
The issue assumes particular significance because it arose from an ongoing criminal investigation. During the course of the child trafficking probe, certain accused persons allegedly claimed to be egg donors associated with an IVF centre. These developments prompted concerns regarding whether fertility clinics and reproductive technology centres could, in isolated cases, be used as fronts for illegal child procurement or trafficking operations. Earlier, the Supreme Court had already directed the Delhi Police to investigate possible violations of the ART regulatory framework connected with the case.
The Court was informed that although the statutory architecture contemplated under the ART Act has formally been established—including the National Board, National Registry, State Boards, and Appropriate Authorities—there remains no specific mechanism dealing with trafficking risks arising from ART and surrogacy practices. The amicus therefore urged the Court to consider directing the formulation of a dedicated protocol addressing identification, reporting, monitoring, and prevention of trafficking activities that may masquerade as legitimate fertility services.
At a broader level, the proceedings have reopened an important policy debate regarding the intersection of reproductive rights and criminal exploitation. Assisted reproductive technologies have transformed family-building options for thousands of individuals and couples. However, as the fertility industry expands, regulators worldwide have increasingly grappled with concerns relating to exploitation, commercialization of reproduction, illegal adoption practices, cross-border surrogacy arrangements, and trafficking risks. Scholars have long cautioned that inadequate oversight in reproductive markets can create opportunities for vulnerable women and children to be exploited by organized networks.
India’s legislative response to these concerns came through the enactment of the ART Act and the Surrogacy Act in 2021. These laws sought to establish a licensing framework for clinics, regulate gamete donation, create registration requirements, and curb commercial surrogacy practices. The legislation was designed to bring transparency and accountability to a sector that had previously operated under fragmented regulation. Yet the concerns raised before the Supreme Court suggest that statutory regulation alone may not be sufficient if enforcement mechanisms do not adequately address trafficking vulnerabilities.
The significance of the Court’s intervention lies in its preventive approach. Unlike many trafficking cases that reach courts after exploitation has already occurred, the present proceedings focus on identifying structural weaknesses before they evolve into widespread criminal patterns. The Bench’s willingness to examine the issue reflects a broader judicial recognition that trafficking networks increasingly adapt to technological and institutional changes. Criminal enterprises rarely operate through traditional methods alone; they often exploit legitimate systems and regulatory gaps to conceal illegal activities.
The concern is not entirely theoretical. Reports from recent investigations have revealed instances where fertility establishments were allegedly used as fronts for baby-selling operations. In one widely reported case investigated by law enforcement authorities, a fertility centre was accused of facilitating the sale of infants under the guise of reproductive treatment services. Such incidents have intensified calls for stronger monitoring mechanisms and greater coordination between health regulators and law enforcement agencies.
The Supreme Court’s examination of the issue also aligns with its broader efforts to tackle human trafficking. Earlier this year, the Court repeatedly observed that trafficking networks are operating across multiple states and stressed the need for coordinated national responses. The Bench has been actively working toward the development of nationwide Standard Operating Procedures for missing children, trafficking investigations, victim identification, rescue mechanisms, and inter-agency coordination. The present concern regarding IVF and surrogacy centres appears to be part of that larger institutional exercise.
From a legal perspective, the proceedings highlight an emerging challenge in regulatory governance. Traditional anti-trafficking laws were largely designed to combat trafficking through conventional channels such as illegal adoption rackets, forced labour, sexual exploitation, or child sale. The rise of sophisticated reproductive technologies introduces entirely new regulatory questions involving medical establishments, fertility clinics, genetic material, donor databases, and surrogacy arrangements. Policymakers must therefore determine whether existing safeguards are sufficient to detect trafficking concealed within these highly specialized systems.
For law students and young professionals, the case provides a valuable illustration of how constitutional courts increasingly engage with complex interdisciplinary issues. The matter sits at the intersection of criminal law, constitutional law, reproductive rights, healthcare regulation, child protection, and public policy. It demonstrates that contemporary legal practice often requires understanding not only statutes and precedents but also technological developments, regulatory systems, and institutional governance structures.
The proceedings also offer insight into the evolving role of amicus curiae in public interest litigation. In complex matters involving systemic concerns, courts frequently rely upon independent experts and senior advocates to identify gaps in implementation and suggest reforms. The present case illustrates how amicus-assisted litigation can move beyond adjudication of individual disputes and contribute to policy development and institutional reform.
Perhaps the most significant aspect of the Court’s response is that it has reframed the issue from a narrow criminal investigation into a broader question of preventive governance. The Court is not merely examining whether trafficking occurred in a particular case. It is asking whether India’s regulatory architecture is adequately equipped to prevent such exploitation from occurring in the future. That distinction is crucial because it reflects a shift from reactive enforcement to proactive protection.
As the Union Government prepares its response, the proceedings are likely to trigger wider discussions regarding oversight of fertility clinics, verification procedures for donors and surrogates, data-sharing mechanisms, regulatory inspections, and coordination between healthcare regulators and investigative agencies. The eventual outcome may significantly influence how reproductive technologies are governed in India.
Ultimately, the Supreme Court’s intervention serves as a reminder that technological advancement and medical innovation must be accompanied by equally robust safeguards. Assisted reproductive technologies have brought hope to countless families, but the legitimacy of such systems depends upon ensuring that they cannot be manipulated for criminal purposes. The Court’s examination of the issue therefore represents not only an effort to combat child trafficking but also a broader attempt to preserve public trust in India’s reproductive healthcare framework.
